Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01208831 : An East Asian Study of LDE225
PhasePhase 1
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- confirmed diagnosis of advanced solid tumor (including medulloblastoma and basal cell
carcinoma)

- blood work criteria

Exclusion Criteria:

- patients with history of brain tumor (except recurrent medulloblastoma) or brain
metastases

- positive HIV, hepatitis B or C

- impaired intestinal function

- impaired heart function

- pregnant or breast-feeding women

Other protocol-defined inclusion/exclusion criteria may apply
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01208831      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740